Keywords: merck, co, surpass, pfizer, cholesterol-lowering, market, new

Merck & Co to surpass Pfizer in cholesterol-lowering market

Article | 17 September 2007

Print This

A new report finds that US drug major Merck & Co will surpass global giant Pfizer as the leading company in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in